BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND HMGA2, HMGI-C, 8091, ENSG00000149948, LIPO, HMGIC, BABL
162 results:

  • 1. Sarcomas With RAD51B Fusions Are Associated With a Heterogeneous Phenotype.
    Chang HY; Dermawan J; Sharma A; Dickson B; Turashvili G; Torrence D; Nucci M; Chiang S; Oliva E; Kirchner M; Stenzinger A; Mechtersheimer G; Antonescu C
    Mod Pathol; 2024 Feb; 37(2):100402. PubMed ID: 38141829
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Verapamil modulates NFAT2 to inhibit tumor growth and potentiates PD1ab immune checkpoint inhibitor therapy in cervical cancer treatment.
    Liao YQ; Fang BB; Wu QX; Dong WY; Deng GM
    J Recept Signal Transduct Res; 2023 Aug; 43(4):93-101. PubMed ID: 38070127
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. uterine MEIS1::NCOA2 Fusion Sarcoma With Lung Metastasis: A Case Report and Review of the Literature.
    Xing D; Meyer CF; Gross JM; Argani P; Hung CF; Wu TC; Vang R; Armstrong DK; Gaillard SL
    Int J Gynecol Pathol; 2024 Jan; 43(1):47-55. PubMed ID: 37043646
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. A View on uterine Leiomyoma Genesis through the Prism of Genetic, Epigenetic and Cellular Heterogeneity.
    Koltsova AS; Efimova OA; Pendina AA
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982825
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
    Välimäki N; Jokinen V; Cajuso T; Kuisma H; Taira A; Dagnaud O; Ilves S; Kaukomaa J; Pasanen A; Palin K; Heikinheimo O; Bützow R; Aaltonen LA; Karhu A
    Am J Hum Genet; 2023 Mar; 110(3):460-474. PubMed ID: 36773604
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Anticancer peptide Q7 suppresses the growth and migration of human endometrial cancer by inhibiting DHCR24 expression and modulating the AKT-mediated pathway.
    Chen CH; Weng TH; Huang KY; Kao HJ; Liao KW; Weng SL
    Int J Med Sci; 2022; 19(14):2008-2021. PubMed ID: 36483599
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Fusion of the
    Panagopoulos I; Andersen K; Gorunova L; Davidson B; Micci F; Heim S
    In Vivo; 2022; 36(6):2654-2661. PubMed ID: 36309352
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Endometrial cancer-Adjacent Tissues Express Higher Levels of cancer-Promoting Genes than the Matched Tumors.
    Kulinczak M; Sromek M; Panek G; Zakrzewska K; Lotocka R; Szafron LM; Chechlinska M; Siwicki JK
    Genes (Basel); 2022 Sep; 13(9):. PubMed ID: 36140779
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Molecular subclass of uterine fibroids predicts tumor shrinkage in response to ulipristal acetate.
    Kolterud Å; Välimäki N; Kuisma H; Patomo J; Ilves ST; Mäkinen N; Kaukomaa J; Palin K; Kaasinen E; Karhu A; Pasanen A; Bützow R; Heikinheimo O; Kopp Kallner H; Aaltonen LA
    Hum Mol Genet; 2023 Mar; 32(7):1063-1071. PubMed ID: 36048862
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Histological and molecular analysis of cellular leiomyoma with sclerosis: linked to hmga2 overexpression.
    Griffin BB; Feng Y; Saini P; Lu X; Bulun S; Chakravarti D; Wei JJ
    Histopathology; 2022 Nov; 81(5):587-599. PubMed ID: 35961656
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. 3'RNA and whole-genome sequencing of archival uterine leiomyomas reveal a tumor subtype with chromosomal rearrangements affecting either hmga2, HMGA1, or PLAG1.
    Jokinen V; Mehine M; Reinikka S; Khamaiseh S; Ahvenainen T; Äyräväinen A; Härkki P; Bützow R; Pasanen A; Vahteristo P
    Genes Chromosomes Cancer; 2023 Jan; 62(1):27-38. PubMed ID: 35822448
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Structure-based discovery of a specific SHP2 inhibitor with enhanced blood-brain barrier penetration from PubChem database.
    Ma Y; Li WY; Sun T; Zhang L; Lu XH; Yang B; Wang RL
    Bioorg Chem; 2022 Apr; 121():105648. PubMed ID: 35180489
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. miR-142-3p simultaneously targets HMGA1, hmga2, HMGB1, and HMGB3 and inhibits tumorigenic properties and in-vivo metastatic potential of human cervical cancer cells.
    Sharma P; Yadav P; Jain RP; Bera AK; Karunagaran D
    Life Sci; 2022 Feb; 291():120268. PubMed ID: 34973275
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. uterine cellular leiomyomas are characterized by common hmga2 aberrations, followed by chromosome 1p deletion and MED12 mutation: morphological, molecular, and immunohistochemical study of 52 cases.
    Dundr P; Gregová M; Hojný J; Krkavcová E; Michálková R; Němejcová K; Bártů M; Hájková N; Laco J; Mára M; Richtárová A; Zima T; Stružinská I
    Virchows Arch; 2022 Feb; 480(2):281-291. PubMed ID: 34626221
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Deficient H2A.Z deposition is associated with genesis of uterine leiomyoma.
    Berta DG; Kuisma H; Välimäki N; Räisänen M; Jäntti M; Pasanen A; Karhu A; Kaukomaa J; Taira A; Cajuso T; Nieminen S; Penttinen RM; Ahonen S; Lehtonen R; Mehine M; Vahteristo P; Jalkanen J; Sahu B; Ravantti J; Mäkinen N; Rajamäki K; Palin K; Taipale J; Heikinheimo O; Bützow R; Kaasinen E; Aaltonen LA
    Nature; 2021 Aug; 596(7872):398-403. PubMed ID: 34349258
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. hmga2-mediated tumorigenesis through angiogenesis in leiomyoma.
    Li Y; Qiang W; Griffin BB; Gao T; Chakravarti D; Bulun S; Kim JJ; Wei JJ
    Fertil Steril; 2020 Nov; 114(5):1085-1096. PubMed ID: 32868105
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Systematic molecular and clinical analysis of uterine leiomyomas from fertile-aged women undergoing myomectomy.
    Äyräväinen A; Pasanen A; Ahvenainen T; Heikkinen T; Pakarinen P; Härkki P; Vahteristo P
    Hum Reprod; 2020 Oct; 35(10):2237-2244. PubMed ID: 32829387
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. An hmga2-p62-ERα axis regulates uterine leiomyomas proliferation.
    Liu B; Chen G; He Q; Liu M; Gao K; Cai B; Qu J; Lin S; Geng A; Li S; Wang K; Mao Z; Wan X; Yan Q
    FASEB J; 2020 Aug; 34(8):10966-10983. PubMed ID: 32592217
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Intravenous leiomyomatosis is inclined to a solid entity different from uterine leiomyoma based on RNA-seq analysis with RT-qPCR validation.
    Wang W; Wang Y; Chen F; Zhang M; Jia R; Liu X; Zhang C; Shao J; Cheng N; Ma G; Zhu Z; Miao Q; Liang Z
    Cancer Med; 2020 Jul; 9(13):4581-4592. PubMed ID: 32372565
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. A clinicopathological and molecular analysis in uterine leiomyomas and concurrent/metachronous peritoneal nodules: New insights into disseminated peritoneal leiomyomatosis.
    Ma Y; Wang S; Liu Q; Lu B
    Pathol Res Pract; 2020 May; 216(5):152938. PubMed ID: 32234244
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 9.